Guidelines: DEGRO Guidelines (Germany): Difference between revisions
(Created page with "{{forproviders}} {{forpolicymakers}} Go back to Germany page '''Primary purpose:''' To establish evidence-based practices for the use of stereotactic radiotherapy and radiosurgery. '''Sponsor, manager or home institution:''' dataOwner::DEGRO. '''Type of information:''' Detailed protocols and evidence-based recommendations for conducting stereotactic radiotherapy and radiosurgery, focusing on specific conditions like brain metastases, early-stage non-small cel...") |
No edit summary |
||
| Line 11: | Line 11: | ||
'''Access to information:''' [https://www.degro.org/ag-stereotaxie/projekte/practice-guidelines-of-the-degro-working-group-stereotactic-radiotherapy-radiosurgery/ Click here to access]. | '''Access to information:''' [https://www.degro.org/ag-stereotaxie/projekte/practice-guidelines-of-the-degro-working-group-stereotactic-radiotherapy-radiosurgery/ Click here to access]. | ||
{{Esophagus}} | |||
{{Stomach}} | |||
{{Small intestine}} | |||
{{Large intestine}} | |||
{{Rectum}} | |||
{{Anus}} | |||
{{Liver}} | |||
{{Gallbladder}} | |||
{{Bile ducts}} | |||
{{Pancreas}} | |||
{{Colon}} | |||
{{Lung}} | |||
{{Trachea}} | |||
{{Bronchi}} | |||
{{Pleura}} | |||
{{Mediastinum}} | |||
{{Eye}} | |||
{{Brain}} | |||
{{Spinal cord}} | |||
{{Kidney}} | |||
{{Ureter}} | |||
{{Bladder}} | |||
{{Urethra}} | |||
{{Peritoneum}} | |||
{{Pericardium}} | |||
{{Retroperitoneum}} | |||
{{Mesothelium}} | |||
Revision as of 20:52, 11 September 2024
Go back to Germany page
Primary purpose: To establish evidence-based practices for the use of stereotactic radiotherapy and radiosurgery.
Sponsor, manager or home institution: DEGRO.
Type of information: Detailed protocols and evidence-based recommendations for conducting stereotactic radiotherapy and radiosurgery, focusing on specific conditions like brain metastases, early-stage non-small cell lung cancer (NSCLC), primary and secondary liver cancer, renal and pancreatic cancer, and ventricular tachycardia. These include best practices for treatment planning, dosing, patient selection, and outcomes assessment. medical procedures; diagnosis. Click here to learn more.
Cancer areas of interest: C15-C26: Digestive system cancers; C30-C39: Lung/chest cancers; C69-C72: Eye and brain cancer; C64-C68: Urinary system cancers; C76-C80: Cancers of unknown or unspecified areas. Click here to learn more.
Access to information: Click here to access.
